Sun Pharmaceutical Industries

RegulatoryAugust 18, 2026

FDA Approves Supplement for Metformin Hydrochloride by Sun Pharma

The FDA has approved a supplemental application (ANDA075967) for Metformin Hydrochloride submitted by Sun Pharmaceutical Industries. This approval confirms the safety and efficacy of Sun Pharma's formulation, allowing it to compete more effectively in the diabetes market.

RegulatoryAugust 15, 2026

FDA grants AP status for Metformin Hydrochloride ANDA077336 by Sun Pharma

The FDA has granted Abbreviated Approval (AP) status for ANDA077336, a supplemental application for Metformin Hydrochloride submitted by Sun Pharmaceutical Industries.

RegulatoryAugust 14, 2026

FDA Accepts Supplement Application for Absorica by Sun Pharma

The FDA has accepted the supplemental application for Absorica (isotretinoin) submitted by Sun Pharmaceutical Industries.

Recent signals(4)

FDA Approves Supplement for Metformin Hydrochloride by Sun Pharma

FDA grants AP status for Metformin Hydrochloride ANDA077336 by Sun Pharma

FDA Accepts Supplement Application for Absorica by Sun Pharma

FDA Approval Letter for Tramadol Hydrochloride by Sun Pharma

Upcoming catalysts

Regulatory activity(3)

FDA Approves Supplement for Metformin Hydrochloride by Sun Pharma

FDA grants AP status for Metformin Hydrochloride ANDA077336 by Sun Pharma

FDA Accepts Supplement Application for Absorica by Sun Pharma

Clinical activity

Competitive activity

Assets

Therapeutic areas

Indications

Get signals before the market moves